Journal of Pediatric Urology
Volume 7, Issue 2 , Pages 137-139 , April 2011

Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentation

Received 2 November 2009 ,Accepted 20 July 2010.

References 

  1. Rink RC. Bladder augmentation, options, outcomes, future. Urol Clin North Am. 1999;26:111–123
  2. Cartwright PC, Snow BW. Bladder autoaugmentation: early clinical experience. J Urol. 1989;142:505
  3. Cartwright PC, Snow BW. Bladder augmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol. 1989;142:1050
  4. Landa HM, Moorhead JD. Detrusorectomy. Probl Pediatr Urol. 1994;8:204–209
  5. Wan J, Grosman HB. Bladder carcinoma in patients age 40 years or younger. Cancer. 1989;64:178
  6. Khoury JM, Freeman JA. Transitional cell carcinoma of the bladder in a patient on clean intermittent catheterization. BJU Int. 1999;84:378
  7. Yaqoob M, McClelland P, Bell GM, Ahmad R, Bakran A. Bladder tumours in paraplegic patients on renal replacement therapy. Lancet. 1991;338:1554
  8. Gaskill S. Development of carcinoma in the aging myelodysplastic population. Pediatr Neurosurg. 1991;17:34
  9. Winkelhorst JY, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol. 2001;27:409
  10. Soergel TM, Cain MP, Misseri R, Gardner TA , Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172:1649–1651
  11. Greenwell TJ, Venn SN, Mundy AR. Augmentation cystoplasty. BJU Int. 2001;88:511–525
  12. Pickard R. Tumour formation within intestinal segments transposed to the urinary tract. World J Urol. 2004;22:227–234
  13. Zabbo A, Kay R. Ureterosigmoidostomy and bladder exstrophy: a long-term follow-up. J Urol. 1986;136:396–398
  14. Hamid R, Greenwell J, Nethercliffe JM, Freeman A, Venn SN, Woodhouse CR. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary?. BJU Int. 2009;104:392–395
  15. Husmann DA. Enterocystoplasty: what is the risk of malignancy? Annual meeting of the American Urological Association. Chicago, IL, USA April 2009;
  16. Austin C, Elliott S, Cooper CS. Patients With spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol. 2007;178:798
  17. Yaqoob M, McClelland P, Bell GM, Ahmad R, Bakran A. Bladder tumours in paraplegic patients on renal replacement therapy. Lancet. 1991;338:1554
  18. Khoury JM, Freeman JA. Transitional cell carcinoma of the bladder in a patient on clean intermittent catherization. BJU Int. 1999;84:378
  19. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80:S254–S264
  20. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transpl. 2004;4:905
  21. Gifford RR, Wofford JE, Edwards WG. Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases. Clin Transpl. 1998;12:65–69
  22. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nat (Lond.). 1999;397:530–534
  23. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation. 2004;77:1777

PII: S1477-5131(10)00400-6

doi: 10.1016/j.jpurol.2010.07.007

Journal of Pediatric Urology
Volume 7, Issue 2 , Pages 137-139 , April 2011

Article Tools

* Image Usage & Resolution